300003 乐普医疗
已收盘 05-15 15:00:00
资讯
新帖
简况
乐普医疗（300003）2026年一季报简析：净利润同比下降34.8%，公司应收账款体量较大
证券之星 · 04-24
乐普医疗（300003）2026年一季报简析：净利润同比下降34.8%，公司应收账款体量较大
【机构调研记录】国泰海通证券调研乐普医疗、甘源食品等7只个股（附名单）
证券之星 · 04-24
【机构调研记录】国泰海通证券调研乐普医疗、甘源食品等7只个股（附名单）
【机构调研记录】中银基金调研乐普医疗、水晶光电
证券之星 · 04-24
【机构调研记录】中银基金调研乐普医疗、水晶光电
乐普医疗：公司将在完成数据整理、统计分析等相关工作后，按相关规定及时披露该项目的临床数据与BD进展情况
证券之星 · 04-23
乐普医疗：公司将在完成数据整理、统计分析等相关工作后，按相关规定及时披露该项目的临床数据与BD进展情况
图解乐普医疗一季报：第一季度单季净利润同比下降34.80%
证券之星 · 04-23
图解乐普医疗一季报：第一季度单季净利润同比下降34.80%
乐普医疗最新公告：子公司拟4.5亿元受让贝塔宁®品种权益
证券之星 · 04-14
乐普医疗最新公告：子公司拟4.5亿元受让贝塔宁®品种权益
乐普医疗跌3.29% 国金证券在近年高位给予增持评级
中金财经 · 04-09
乐普医疗跌3.29% 国金证券在近年高位给予增持评级
乐普医疗（300003）披露乐普转2到期兑付暨摘牌补充提示公告，3月26日股价下跌2.79%
证券之星 · 03-26
乐普医疗（300003）披露乐普转2到期兑付暨摘牌补充提示公告，3月26日股价下跌2.79%
乐普医疗（300003）披露乐普转2到期兑付暨摘牌公告，3月23日股价下跌7.4%
证券之星 · 03-23
乐普医疗（300003）披露乐普转2到期兑付暨摘牌公告，3月23日股价下跌7.4%
乐普医疗（300003）披露2026年第一次临时股东会决议公告，3月20日股价下跌3.12%
证券之星 · 03-20
乐普医疗（300003）披露2026年第一次临时股东会决议公告，3月20日股价下跌3.12%
乐普医疗（300003）披露股东股份解除质押公告，3月16日股价上涨4.19%
证券之星 · 03-16
乐普医疗（300003）披露股东股份解除质押公告，3月16日股价上涨4.19%
乐普生物：阿斯利康已支付ADC候选药物CMG901里程碑款项
经济参考网 · 03-11
乐普生物：阿斯利康已支付ADC候选药物CMG901里程碑款项
乐普医疗（300003）披露召开2026年第一次临时股东会通知，3月4日股价下跌1.53%
证券之星 · 03-04
乐普医疗（300003）披露召开2026年第一次临时股东会通知，3月4日股价下跌1.53%
乐普医疗最新公告：控股子公司MWX401注射液获得药物临床试验批准通知书
证券之星 · 03-01
乐普医疗最新公告：控股子公司MWX401注射液获得药物临床试验批准通知书
乐普医疗（300003）披露乐普转2即将到期及停止交易的第三次提示性公告，2月26日股价下跌0.82%
证券之星 · 02-26
乐普医疗（300003）披露乐普转2即将到期及停止交易的第三次提示性公告，2月26日股价下跌0.82%
乐普医疗（300003）披露乐普转2即将到期及停止交易的第二次提示性公告，2月25日股价上涨2.92%
证券之星 · 02-25
乐普医疗（300003）披露乐普转2即将到期及停止交易的第二次提示性公告，2月25日股价上涨2.92%
乐普医疗（300003）披露乐普转2即将到期及停止交易的第一次提示性公告，2月24日股价上涨0.17%
证券之星 · 02-24
乐普医疗（300003）披露乐普转2即将到期及停止交易的第一次提示性公告，2月24日股价上涨0.17%
乐普医疗最新公告：2025年净利同比预增224%-386%
证券之星 · 01-28
乐普医疗最新公告：2025年净利同比预增224%-386%
乐普医疗独立董事甘亮任期届满离任，将继续履职至新任到位
中金财经 · 01-21
乐普医疗独立董事甘亮任期届满离任，将继续履职至新任到位
1月8日乐普医疗涨5.99%，汇添富民营活力混合基金重仓该股
证券之星 · 01-08
1月8日乐普医疗涨5.99%，汇添富民营活力混合基金重仓该股
暂无数据
公司概况
公司名称：
乐普(北京)医疗器械股份有限公司
所属行业：
专用设备制造业
上市日期：
2009-10-30
主营业务：
乐普(北京)医疗器械股份有限公司的主营业务是医疗器械及其配件的技术开发、生产，销售。公司的主要产品是医疗器械、药品、医疗服务、健康管理。公司拥有国家科技部授予的“国家心脏病植介入诊疗器械及装备工程技术研究中心”称号。
发行价格：
29.00
{"stockData":{"symbol":"300003","market":"SZ","secType":"STK","nameCN":"乐普医疗","latestPrice":13.63,"timestamp":1778828592000,"preClose":13.72,"halted":0,"volume":25675114,"delay":0,"changeRate":-0.0066,"floatShares":1579000000,"shares":1843000000,"eps":0.4505,"marketStatus":"已收盘","change":-0.09,"latestTime":"05-15 15:00:00","open":13.67,"high":13.85,"low":13.53,"amount":351000000,"amplitude":0.0233,"askPrice":13.63,"askSize":294,"bidPrice":13.62,"bidSize":482,"shortable":0,"etf":0,"ttmEps":0.4505,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779067800000},"marketStatusCode":5,"adr":0,"adjPreClose":13.72,"symbolType":"stock","openAndCloseTimeList":[[1778808600000,1778815800000],[1778821200000,1778828400000]],"highLimit":15.09,"lowLimit":12.35,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1843424716,"isCdr":false,"pbRate":1.54,"roa":"--","peRate":30.255272,"roe":"1.52%","epsLYR":0.5219,"committee":0.309635,"marketValue":25126000000,"turnoverRate":0.0163,"status":1,"floatMarketCap":21521000000},"requestUrl":"/m/hq/s/300003/tweets","defaultTab":"tweets","newsList":[{"id":"2629840037","title":"乐普医疗（300003）2026年一季报简析：净利润同比下降34.8%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2629840037","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629840037?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:34","pubTimestamp":1777041290,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期乐普医疗发布2026年一季报。截至本报告期末，公司营业总收入16.72亿元，同比下降3.7%，归母净利润2.47亿元，同比下降34.8%。本报告期乐普医疗公司应收账款体量较大，当期应收账款占最新年报归母净利润比达232.94%。然而去年的净利率为15.72%，算上全部成本后，公司产品或服务的附加值高。持有乐普医疗最多的基金为医疗器械ETF永赢，目前规模为55.46亿元，最新净值0.4849，较上一交易日下跌0.66%，近一年上涨4.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400065327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300003"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629862487","title":"【机构调研记录】国泰海通证券调研乐普医疗、甘源食品等7只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2629862487","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629862487?lang=zh_cn&edition=full","pubTime":"2026-04-24 08:04","pubTimestamp":1776989056,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月23日披露的机构调研信息，国泰海通证券近期对7家上市公司进行了调研。部分品类均价上升系销售结构变化所致，非普遍提价。5）蓝晓科技 调研纪要：2025年公司金属资源领域收入3.16亿元，同比增长23%，在提镍、提钒、提镓等领域取得突破。与2025年第四季度相比，营业收入和净利润环比均有所增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400023459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","161027","BK0042","02611","BK0188","BK0183","BK0238","BK1564","601211","BK0196","BK0276","BK0114","002991","300003","BK0201","BK0028","BK0113","BK0184","BK0012","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629625678","title":"【机构调研记录】中银基金调研乐普医疗、水晶光电","url":"https://stock-news.laohu8.com/highlight/detail?id=2629625678","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629625678?lang=zh_cn&edition=full","pubTime":"2026-04-24 08:02","pubTimestamp":1776988978,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及4月23日披露的机构调研信息，中银基金近期对2家上市公司进行了调研，相关名单如下：1）乐普医疗 个股亮点：乐普瑞康(北京)养老服务管理有限公司为公司的子公司，公司持有其70.18%股权，主要从事老人养老服务，护理服务。；水晶光电储能5MW/10MWh项目已投运。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400023373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0201","BK0028","BK0113","BK0198","BK0196","BK0109","BK0188","BK0070","BK0251","002273","300003","BK0108","BK0064","BK0197","BK0214","BK0042","BK0072","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629883429","title":"乐普医疗：公司将在完成数据整理、统计分析等相关工作后，按相关规定及时披露该项目的临床数据与BD进展情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2629883429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629883429?lang=zh_cn&edition=full","pubTime":"2026-04-23 15:45","pubTimestamp":1776930312,"startTime":"0","endTime":"0","summary":"证券之星消息，乐普医疗(300003)04月23日在投资者关系平台上答复投资者关心的问题。投资者提问：公司重磅创新药MWN109注射液二期低剂量组临床试验已经结束，临床数据何时公布？公司对该管线对外BD授权的预期和安排如何？乐普医疗回复：尊敬的投资者您好，目前该临床研究数据尚未揭盲，公司将在完成数据整理、统计分析等相关工作后，按相关规定及时披露该项目的临床数据与BD进展情况，请您关注公司官方公告，感谢您对公司的关心。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300039606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0251","300003","BK0113","BK0042","BK0188","BK0114","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629202437","title":"图解乐普医疗一季报：第一季度单季净利润同比下降34.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629202437","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629202437?lang=zh_cn&edition=full","pubTime":"2026-04-23 02:29","pubTimestamp":1776882581,"startTime":"0","endTime":"0","summary":"证券之星消息，乐普医疗2026年一季报显示，一季度公司主营收入16.72亿元，同比下降3.7%；归母净利润2.47亿元，同比下降34.8%；扣非净利润2.41亿元，同比下降28.45%；负债率29.75%，投资收益73.9万元，财务费用1.38亿元，毛利率62.03%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300004466.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300003"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627464614","title":"乐普医疗最新公告：子公司拟4.5亿元受让贝塔宁®品种权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2627464614","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627464614?lang=zh_cn&edition=full","pubTime":"2026-04-14 20:30","pubTimestamp":1776169829,"startTime":"0","endTime":"0","summary":"乐普医疗公告称，公司子公司乐普药业与百奥泰签署协议，以4.5亿元(含税)受让贝塔宁制剂及原料药品种权益及相关资产与业务。款项分五期支付，在完成MAH转移及生产转移获批后付清。此外，乐普药业还将按目标药品年度净销售额的个位数百分比获取销售分成，最长分成期为10年。该药品为化学药品1类创新药，主要用于PCI术后急性冠脉综合征患者。本次交易不构成关联交易及重大资产重组，无需提交董事会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041400035618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0113","BK0042","BK0201","300003","BK0251","BK0188","BK0028","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626188663","title":"乐普医疗跌3.29% 国金证券在近年高位给予增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2626188663","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626188663?lang=zh_cn&edition=full","pubTime":"2026-04-09 17:33","pubTimestamp":1775727189,"startTime":"0","endTime":"0","summary":"中国经济网北京4月9日讯 乐普医疗(300003.SZ)今日收报16.19元，跌幅3.29%。\r\n\r\n 乐普医疗1月14日股价盘中达到2024年以来最高点21.60元。\r\n\r\n 乐普医疗今年仅1篇券商研报。国金证券股份有限公司研究员杨欣、赵中平、杨雨钦1月7日发布研报《乐普医疗(300003)：严肃医疗强背景 医美筑新增长极》称，首次覆盖给予“增持”评级。\r\n\r\n (责任编辑：徐自立)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260409/32134172.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300003"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622539866","title":"乐普医疗（300003）披露乐普转2到期兑付暨摘牌补充提示公告，3月26日股价下跌2.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622539866","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622539866?lang=zh_cn&edition=full","pubTime":"2026-03-26 22:06","pubTimestamp":1774533988,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘，乐普医疗报收于15.67元，较前一交易日下跌2.79%，最新总市值为288.86亿元。乐普（北京）医疗器械股份有限公司于近日发布《关于乐普转2到期兑付暨摘牌的补充提示公告》。公告显示，“乐普转2”可转换公司债券到期日为2026年3月29日，兑付登记日为2026年3月27日，到期兑付价格为107.80元/张（含税），预计税后实际派发107.44元/张。截至兑付登记日未转股的债券将被强制赎回并摘牌。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600043825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0114","BK0042","BK0251","BK0113","BK0188","BK0196","300003","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621771707","title":"乐普医疗（300003）披露乐普转2到期兑付暨摘牌公告，3月23日股价下跌7.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621771707","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621771707?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:48","pubTimestamp":1774259330,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，乐普医疗报收于15.52元，较前一交易日下跌7.4%，最新总市值为286.1亿元。该股当日开盘16.45元，最高16.46元，最低15.4元，成交额达8.01亿元，换手率为3.21%。乐普医疗于近日披露《关于乐普转2到期兑付暨摘牌的公告》。公告显示，“乐普转2”可转债将于2026年3月29日到期，兑付登记日为2026年3月27日，到期兑付价格为107.80元/张。未转股的“乐普转2”将被强制赎回并摘牌。兑付资金将于2026年3月30日发放。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300027562.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300003","BK0113","BK0114","BK0042","BK0196","BK0188","BK0201","BK0028","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620734128","title":"乐普医疗（300003）披露2026年第一次临时股东会决议公告，3月20日股价下跌3.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620734128","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620734128?lang=zh_cn&edition=full","pubTime":"2026-03-20 22:05","pubTimestamp":1774015527,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，乐普医疗报收于16.76元，较前一交易日下跌3.12%，最新总市值为308.95亿元。该股当日开盘17.38元，最高17.48元，最低16.73元，成交额达5.7亿元，换手率为2.11%。乐普医疗于近日发布《2026年第一次临时股东会决议公告》。公告显示，公司于2026年3月20日召开2026年第一次临时股东会，审议通过补选第六届董事会独立董事的议案。出席会议股东共478人，代表股份占公司有表决权股份总数的22.7554%。表决结果合法有效，律师出具法律意见书确认会议合规。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000042826.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300003","BK0113","BK0114","BK0042","BK0196","BK0188","BK0201","BK0028","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619469715","title":"乐普医疗（300003）披露股东股份解除质押公告，3月16日股价上涨4.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619469715","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619469715?lang=zh_cn&edition=full","pubTime":"2026-03-16 22:03","pubTimestamp":1773669803,"startTime":"0","endTime":"0","summary":"截至2026年3月16日收盘，乐普医疗报收于18.41元，较前一交易日上涨4.19%，最新总市值为339.37亿元。乐普医疗于2026年3月16日披露《关于股东股份解除质押的公告》。公告显示，公司股东WP MEDICAL TECHNOLOGIES, INC办理了股份解除质押，解除质押股份数量为85,000,000股，占其所持股份比例18.65%，占公司总股本比例4.61%。截至公告日，蒲忠杰及其一致行动人合计持有公司股份455,643,349股，占公司总股本24.72%，累计质押股份124,159,994股，占公司总股本6.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600035923.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0201","BK0196","BK0042","300003","BK0251","BK0113","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618594382","title":"乐普生物：阿斯利康已支付ADC候选药物CMG901里程碑款项","url":"https://stock-news.laohu8.com/highlight/detail?id=2618594382","media":"经济参考网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618594382?lang=zh_cn&edition=full","pubTime":"2026-03-11 17:40","pubTimestamp":1773222000,"startTime":"0","endTime":"0","summary":"得益于主要产品商业化收入增加以及不断扩大的BD交易，乐普生物科技股份有限公司（证券简称“乐普生物”，02157.HK）2025年扭亏为盈，公司3月11日披露最新的BD进展——由公司参股公司研发的A ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20260311/c675223059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["300003","BK0042","BK0251","BK0113","BK0201","BK0188","BK0028","BK0196","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616655689","title":"乐普医疗（300003）披露召开2026年第一次临时股东会通知，3月4日股价下跌1.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616655689","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616655689?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:05","pubTimestamp":1772633119,"startTime":"0","endTime":"0","summary":"截至2026年3月4日收盘，乐普医疗报收于16.75元，较前一交易日下跌1.53%，最新总市值为308.77亿元。近日，乐普（北京）医疗器械股份有限公司发布《关于召开2026年第一次临时股东会的通知》。公告显示，公司将于2026年3月20日召开2026年第一次临时股东会，会议由董事会召集，现场会议地点为北京市昌平区超前路37号7号楼公司会议室。登记时间为2026年3月18日至19日，股东可通过现场、信函、电子邮件或传真方式登记。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400039747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0113","BK0196","BK0028","BK0042","BK0114","300003","BK0201","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616266118","title":"乐普医疗最新公告：控股子公司MWX401注射液获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2616266118","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616266118?lang=zh_cn&edition=full","pubTime":"2026-03-01 16:20","pubTimestamp":1772353206,"startTime":"0","endTime":"0","summary":"乐普医疗(300003.SZ)公告称，公司控股子公司上海民为生物技术有限公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意MWX401注射液开展临床试验。该药物为小干扰RNA（siRNA）药物，用于治疗原发性高血压，拥有全球知识产权。然而，该在研项目尚处于研发早期阶段，后续临床试验存在结果不确定性高、研发投入大、临床试验周期长等特点，药品存在临床试验失败的风险。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100003883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0114","BK0042","BK0251","BK0113","BK0188","BK0196","300003","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614324023","title":"乐普医疗（300003）披露乐普转2即将到期及停止交易的第三次提示性公告，2月26日股价下跌0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614324023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614324023?lang=zh_cn&edition=full","pubTime":"2026-02-26 22:39","pubTimestamp":1772116755,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘，乐普医疗报收于18.18元，较前一交易日下跌0.82%，最新总市值为335.13亿元。该股当日开盘18.28元，最高18.3元，最低18.07元，成交额达4.76亿元，换手率为1.66%。近日，乐普医疗发布公告，可转换公司债券“乐普转2”到期日为2026年3月29日，兑付登记日为2026年3月27日，到期兑付价格为107.80元/张。最后交易日为2026年3月24日，停止交易日为2026年3月25日，最后转股日为2026年3月27日。截至该日收市后未转股的债券将被强制赎回并摘牌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0028","BK0188","BK0042","BK0251","BK0114","300003","BK0196","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614038706","title":"乐普医疗（300003）披露乐普转2即将到期及停止交易的第二次提示性公告，2月25日股价上涨2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614038706","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614038706?lang=zh_cn&edition=full","pubTime":"2026-02-25 22:11","pubTimestamp":1772028676,"startTime":"0","endTime":"0","summary":"截至2026年2月25日收盘，乐普医疗报收于18.33元，较前一交易日上涨2.92%，最新总市值为337.89亿元。该股当日开盘17.95元，最高18.43元，最低17.95元，成交额达6.65亿元，换手率为2.3%。近日，乐普医疗发布公告，可转换公司债券“乐普转2”到期日为2026年3月29日，兑付登记日为2026年3月27日，到期兑付价格为107.80元/张。最后交易日为2026年3月24日，自2026年3月25日起停止交易。最后转股日为2026年3月27日，未转股的债券将被强制赎回并摘牌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022500037919.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300003","BK0028","BK0188","BK0251","BK0114","BK0196","BK0201","BK0113","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613717415","title":"乐普医疗（300003）披露乐普转2即将到期及停止交易的第一次提示性公告，2月24日股价上涨0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613717415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613717415?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:09","pubTimestamp":1771942154,"startTime":"0","endTime":"0","summary":"截至2026年2月24日收盘，乐普医疗报收于17.81元，较前一交易日上涨0.17%，最新总市值为328.31亿元。该股当日开盘17.91元，最高18.05元，最低17.75元，成交额达3.99亿元，换手率为1.41%。近日，乐普医疗发布公告，可转债“乐普转2”到期日为2026年3月29日，兑付登记日为2026年3月27日，到期兑付价格为107.80元/张。最后交易日为2026年3月24日，停止交易日为2026年3月25日，最后转股日为2026年3月27日。截至该日收市后未转股的债券将被强制赎回并摘牌。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022400043821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0251","BK0196","BK0113","BK0042","300003","BK0188","BK0114","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606791494","title":"乐普医疗最新公告：2025年净利同比预增224%-386%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606791494","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606791494?lang=zh_cn&edition=full","pubTime":"2026-01-28 17:31","pubTimestamp":1769592699,"startTime":"0","endTime":"0","summary":"乐普医疗(300003.SZ)公告称，乐普医疗预计2025年归属于上市公司股东的净利润为8亿元-12亿元，比上年同期增长223.97%-385.95%。主要因心血管植介入业务稳增、药品零售渠道库存清理完成带动制剂收入双位数增长，创新药及皮肤科等新兴板块贡献增量；民为生物MWN105项目有偿许可获3000万美元首付款；人员优化和组织重塑推动销售及管理费用下降。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800029932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0114","BK0042","BK0251","BK0113","BK0188","BK0196","300003","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605177356","title":"乐普医疗独立董事甘亮任期届满离任，将继续履职至新任到位","url":"https://stock-news.laohu8.com/highlight/detail?id=2605177356","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605177356?lang=zh_cn&edition=full","pubTime":"2026-01-21 17:09","pubTimestamp":1768986542,"startTime":"0","endTime":"0","summary":"目前，甘亮先生未持有公司股份。由于甘亮先生的离任将导致公司独立董事人数低于董事会成员总数的三分之一，且相关专门委员会中独立董事不足半数，为保障公司董事会规范运作，甘亮先生需继续履行其独立董事及在董事会各专门委员会中的职责，直至公司股东大会选举产生新任独立董事。公司董事会表示将尽快完成独立董事及相关专门委员会职务的补选工作，并对甘亮先生在任职期间的勤勉工作和贡献表示感谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260121/31960520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0188","BK0028","300003","BK0201","BK0251","BK0042","BK0113","BK0114","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601603356","title":"1月8日乐普医疗涨5.99%，汇添富民营活力混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601603356","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601603356?lang=zh_cn&edition=full","pubTime":"2026-01-08 15:38","pubTimestamp":1767857915,"startTime":"0","endTime":"0","summary":"证券之星消息，1月8日乐普医疗涨5.99%，收盘报19.64元，换手率11.04%，成交量174.32万手，成交额33.91亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共58家，其中持有数量最多的公募基金为汇添富基金的汇添富民营活力混合。汇添富民营活力混合目前规模为33.48亿元，最新净值7.543，较上一交易日上涨0.96%，近一年上涨79.42%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800019304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0188","300003","BK0042","BK0113","BK0028","BK0196","BK0251","BK0201"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778989380744,"stockEarnings":[{"period":"1week","weight":-0.0594},{"period":"1month","weight":-0.1784},{"period":"3month","weight":-0.2334},{"period":"6month","weight":-0.1877},{"period":"1year","weight":0.2328},{"period":"ytd","weight":-0.1379}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.0131},{"period":"6month","weight":0.0363},{"period":"1year","weight":0.2232},{"period":"ytd","weight":0.042}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"乐普(北京)医疗器械股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"108751人(较上一季度增加27.41%)","perCapita":"14518股","listingDate":"2009-10-30","address":"北京市昌平区超前路37号","registeredCapital":"184342万元","survey":" 乐普(北京)医疗器械股份有限公司的主营业务是医疗器械及其配件的技术开发、生产，销售。公司的主要产品是医疗器械、药品、医疗服务、健康管理。公司拥有国家科技部授予的“国家心脏病植介入诊疗器械及装备工程技术研究中心”称号。","listedPrice":29},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"乐普医疗(300003)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供乐普医疗(300003)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"乐普医疗,300003,乐普医疗股票,乐普医疗股票老虎,乐普医疗股票老虎国际,乐普医疗行情,乐普医疗股票行情,乐普医疗股价,乐普医疗股市,乐普医疗股票价格,乐普医疗股票交易,乐普医疗股票购买,乐普医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"乐普医疗(300003)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供乐普医疗(300003)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}